News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,746 Results
Type
Article (39535)
Company Profile (247)
Press Release (655964)
Section
Business (204094)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81007)
Employer Resources (172)
FDA (16150)
Job Trends (14842)
News (345029)
Policy (32495)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49362)
ALS (81)
Alzheimer's disease (1345)
Antibody-drug conjugate (ADC) (107)
Approvals (16150)
Artificial intelligence (225)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (175)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (245)
Cancer (1959)
Cardiovascular disease (149)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (392)
Cervical cancer (17)
Clinical research (65652)
Collaboration (757)
Compensation (446)
Complete response letters (18)
COVID-19 (2581)
CRISPR (34)
C-suite (203)
Cystic fibrosis (98)
Data (1905)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (241)
Diagnostics (6326)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86119)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111571)
Executive appointments (626)
FDA (17235)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (681)
Gene editing (94)
Generative AI (18)
Gene therapy (271)
GLP-1 (677)
Government (4377)
Grass and pollen (4)
Guidances (48)
Healthcare (18802)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (102)
Indications (26)
Infectious disease (2709)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (83)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (449)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (264)
MASH (59)
Medical device (13312)
Medtech (13317)
Mergers & acquisitions (19391)
Metabolic disorders (620)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1806)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2387)
Now hiring (37)
Obesity (337)
Opinion (201)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57046)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20447)
Phase II (28914)
Phase III (21544)
Pipeline (961)
Podcasts (44)
Policy (107)
Postmarket research (2563)
Preclinical (8648)
Press Release (64)
Prostate cancer (91)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (352)
Real estate (5900)
Recruiting (65)
Regulatory (22110)
Reports (46)
Research institute (2316)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (62)
Series A (120)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2058)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (25)
United States (20841)
Vaccines (652)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (16)
Last 7 days (553)
Last 30 days (2417)
Last 365 days (33482)
2025 (7640)
2024 (35218)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54084)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37685)
Australia (6161)
California (5439)
Canada (1853)
China (466)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (80790)
Florida (809)
Georgia (190)
Idaho (57)
Illinois (488)
India (23)
Indiana (289)
Iowa (9)
Japan (138)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (822)
Massachusetts (4088)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1548)
New Mexico (28)
New York (1561)
North Carolina (908)
North Dakota (7)
Northern California (2387)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1237)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2058)
Tennessee (92)
Texas (809)
Utah (163)
Virginia (127)
Washington D.C. (57)
Washington State (506)
West Virginia (3)
Wisconsin (48)
695,746 Results for "vaxart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 27, 2025
March 28, 2025
·
2 min read
Press Releases
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
March 20, 2025
·
12 min read
Press Releases
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
March 12, 2025
·
5 min read
Press Releases
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
March 13, 2025
·
1 min read
Biotech Bay
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23, 2024
Vaxart, Inc. announced that on May 17, 2024, the Compensation Committee of the Board of Directors granted inducement equity awards covering an aggregate of 22,500 shares of its common stock to one new non-executive employee to induce him to accept employment with Vaxart.
May 23, 2024
·
2 min read
Biotech Bay
Vaxart Provides Business Update - June 17, 2024
Vaxart, Inc. provided business and cash runway updates as the Company continues to advance its oral pill vaccine platform.
June 17, 2024
·
8 min read
Press Releases
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
January 28, 2025
·
6 min read
Business
Vaxart, Inc. Announces Management Change - Jan 16, 2024
Vaxart, Inc. announced a change in management. Effective immediately Andrei Floroiu, President and Chief Executive Officer of Vaxart, has announced his resignation from his positions with Vaxart as President, Chief Executive Officer, and Director on Vaxart’s Board of Directors.
January 16, 2024
·
5 min read
Press Releases
Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs
January 15, 2025
·
9 min read
Press Releases
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
March 6, 2025
·
8 min read
1 of 69,575
Next